Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 (NeoTRIPaPDL1)

Clinical Trial ID NCT02620280

PubWeight™ 2.81‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02620280

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 2016 1.18
2 Triple-negative breast cancer: treatment challenges and solutions. Breast Cancer (Dove Med Press) 2016 0.95
3 Biology and Management of Patients With Triple-Negative Breast Cancer. Oncologist 2016 0.84
Next 100